BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9157737)

  • 1. [Cost effectiveness and evaluation of a structured therapy and education program for insulin-treated type II diabetic patients in Bradenburg].
    Schlottmann N; Grüsser M; Hartmann P; Jörgens V
    Z Arztl Fortbild (Jena); 1996 Aug; 90(5):441-4. PubMed ID: 9157737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structured treatment and teaching programme for type 2 diabetic patients on conventional insulin treatment: evaluation of reimbursement policy.
    Gruesser M; Hartmann P; Schlottmann N; Joergens V
    Patient Educ Couns; 1996 Oct; 29(1):123-30. PubMed ID: 9006229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should insulin therapy in type 2 diabetic patients be started on an out- or inpatient basis? Results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital.
    Müller UA; Müller R; Starrach A; Hunger-Dathe W; Schiel R; Jörgens V; Grüsser M
    Diabetes Metab; 1998 Jun; 24(3):251-5. PubMed ID: 9690059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing the gap between literature and practice: evaluation of a teaching programme (in the absence of a structured treatment) on both type 1 and type 2 diabetes.
    Matteucci E; Giampietro O
    Diabetes Nutr Metab; 2003; 16(5-6):298-305. PubMed ID: 15000441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetology in the German medical system in 1998].
    Jörgens V; Grüsser M
    Diabetes Metab; 1998 Nov; 24 Suppl 3():18-23. PubMed ID: 9881228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structured treatment of diabetes in the country].
    Ecker J; Witzmann G; Gmeiner H; Aigner I; Said H
    Wien Med Wochenschr; 2005 Aug; 155(15-16):371-5. PubMed ID: 16160925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
    Schiel R; Ulbrich S; Müller UA
    Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concept and outcome of general practice quality circles on the topic of diabetes mellitus].
    Prettin C; Schulze J; Rothe U
    Z Arztl Fortbild (Jena); 1996 Aug; 90(5):428-33. PubMed ID: 9157735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H; Vondeling H; de Witte LP; Hutubessy RC; van Beekum WT; Heine RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):166-71. PubMed ID: 11845567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a structured treatment and teaching program for non-insulin-treated type II diabetic outpatients in Germany after the nationwide introduction of reimbursement policy for physicians.
    Gruesser M; Bott U; Ellermann P; Kronsbein P; Joergens V
    Diabetes Care; 1993 Sep; 16(9):1268-75. PubMed ID: 8404431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association).
    Müller UA; Femerling M; Reinauer KM; Risse A; Voss M; Jörgens V; Berger M; Mühlhauser I
    Diabetes Care; 1999 Mar; 22 Suppl 2():B29-34. PubMed ID: 10097896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes disease management program. What is its purpose?].
    Stoschek J
    MMW Fortschr Med; 2006 May; 148(19):49, 51. PubMed ID: 16736710
    [No Abstract]   [Full Text] [Related]  

  • 17. [The German diabetes dilemma: DMP: insufficient management of the diabetic patient in general practice?].
    MMW Fortschr Med; 2005 Oct; 147(41):10. PubMed ID: 16270503
    [No Abstract]   [Full Text] [Related]  

  • 18. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
    Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
    J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.